MarketPeel
Insider Trading Intelligence
Pricing
…
NV

Nicki Vasquez

STRO
CHIEF PORT. STRAT & ALNCE OFCR · SUTRO BIOPHARMA, INC. · CIK 0001877585
FILING MIX · LIFETIME41%/59%
BUYS
12
SELLS
17
TOTAL VALUE
$250.8K
COMPANIES
1
ACTIVE SINCE
Sep 2021
HOLDINGS NOW
12,803
AVG SELL PX
$8.48
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Nicki Vasquez, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-5.40%+0.06%-5.46%-5.46%—
14d2+50.00%+0.07%+0.98%-0.91%-0.91%—
30d2+0.00%+5.58%+4.36%+1.22%+1.22%—
60d2+50.00%-0.31%+6.31%-6.62%-6.62%—
90d2+100.00%-25.94%+7.29%-33.23%-33.23%—
180d2+100.00%-32.94%+8.67%-41.61%-41.61%—
1y2+100.00%-65.95%+5.68%-71.62%-71.62%—
2y2+100.00%-74.85%+22.84%-97.69%-97.69%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
STRO · 12,803 shares · as of Jan 29, 2024
09,00018,00027,00036,000202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
FLOW · 12 buys / 17 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
CHIEF PORT. STRAT & ALNCE OFCR
2,500——15,303Jan 29, 2024Jan 31, 2024 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
CHIEF PORT. STRAT & ALNCE OFCR
1,024$4.99$5.1K14,279Jan 29, 2024Jan 31, 2024 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
CHIEF PORT. STRAT & ALNCE OFCR
2,500——0Jan 29, 2024Jan 31, 2024 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE10b5-1
10b5-1 plan
12,185$5.00$60.9K12,803Jan 29, 2024Jan 31, 2024 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
5,500——27,851Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
5,500——11,000Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
6,750——22,351Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
4,990$5.79$28.9K22,861Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
6,750——20,250Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Mar 3, 2023Mar 7, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
1,019$7.50$7.6K15,601Jan 27, 2023Jan 31, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
2,500——16,620Jan 27, 2023Jan 31, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
2,500——2,500Jan 27, 2023Jan 31, 2023 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
3,250——15,243Jul 12, 2022Jul 13, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
3,250——9,750Jul 12, 2022Jul 13, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
1,123$6.08$6.8K14,120Jul 12, 2022Jul 13, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
2,253$8.17$18.4K11,993Mar 5, 2022Mar 7, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
5,500——14,246Mar 5, 2022Mar 7, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
5,500——16,500Mar 5, 2022Mar 7, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
36,000——36,000Mar 4, 2022Mar 7, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
27,000——27,000Mar 4, 2022Mar 7, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
2,500——5,000Jan 29, 2022Feb 1, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
2,500——9,770Jan 29, 2022Feb 1, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
1,024$10.39$10.6K8,746Jan 29, 2022Feb 1, 2022 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
3,906$18.62$72.7K7,270Sep 28, 2021Sep 28, 2021 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
2,063$19.23$39.7K11,176Sep 24, 2021Sep 28, 2021 ↗View →
STRO
SUTRO BIOPHARMA, INC.
PURCHASE
Chief Port. Strat & Alnce Ofcr
5,969——13,239Sep 24, 2021Sep 28, 2021 ↗View →
STRO
SUTRO BIOPHARMA, INC.
SALE
Chief Port. Strat & Alnce Ofcr
5,969——0Sep 24, 2021Sep 28, 2021 ↗View →
Other insiders · STRO
Loading peer insiders…
About this filer
CIK 0001877585
ROLE
Chief Port. Strat & Alnce Ofcr
PRIMARY
STRO
COMPANIES
1
ACTIVE SINCE
Sep 2021
MARKETPEEL · /INSIDER/0001877585DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback